Korro Bio (KRRO) Other Operating Expenses (2018 - 2025)

Korro Bio's (KRRO) quarterly Other Operating Expenses came in at $34.5 million in Q4 2025, down 36.96% on a QoQ basis from $54.8 million in Q4 2023.

Korro Bio (KRRO) Other Operating Expenses (2018 - 2025) Analysis & Trends

Korro Bio (KRRO) has 5 years of Other Operating Expenses data on file, last reported at $34.5 million in Q4 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to $34.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $34.5 million (changed N/A YoY) and the FY2025 annual result came in at $30.9 million, changed N/A from the prior year.
Other Operating Expenses slipped to $34.5 million in Q4 2025, from $54.8 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $54.8 million in Q4 2023 to a low of $34.5 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Korro Bio	231.77 Mn	116.73 Mn	-

Download Data